The role of the agonist binding site in Ca 2+ inhibition of the recombinant 5-HT 3A receptor

By Niemeyer M.I.   Lummis S.C.R.  

European Journal of Pharmacology, Vol. 428, Iss. 2, 2001-10 ,pp. : 153-161

Elsevier

Access to resources Recommend Favorite

5-HT₃ receptor antagonists

By Higgins G.A.   Kilpatrick G.J.  

Expert Opinion on Investigational Drugs, Vol. 8, Iss. 12, 1999-12 ,pp. : 2183-2188

Informa Healthcare

Access to resources Recommend Favorite

Head and whole-body jerking in guinea pigs are differentially modulated by 5-HT 1A , 5-HT 1B/1D and 5-HT 2A receptor antagonists

By Nielsen C.K.  

European Journal of Pharmacology, Vol. 361, Iss. 2, 1998-11 ,pp. : 185-190

Elsevier

Access to resources Recommend Favorite

Enhancement of antipsychotic-like properties of the dopamine D 2 receptor antagonist, raclopride, by the additional treatment with the 5-HT 2 receptor blocking agent, ritanserin, in the rat

By Wadenberg M.-L.   Salmi P.   Jimenez P.   Svensson T.   Ahlenius S.  

European Neuropsychopharmacology, Vol. 6, Iss. 4, 1996-11 ,pp. : 305-310

Elsevier

Access to resources Recommend Favorite

Effects of peripheral 5-HT 2 and 5-HT 3 receptor agonists on food intake in food-deprived and 2-deoxy-d-glucose-treated rats

By Sugimoto Y.   Yamada J.   Yoshikawa T.   Noma T.   Horisaka K.  

European Journal of Pharmacology, Vol. 316, Iss. 1, 1996-11 ,pp. : 15-21

Elsevier

Access to resources Recommend Favorite